152 related articles for article (PubMed ID: 18438711)
1. Resveratrol protects rat striatal slices against anoxia-induced dopamine release.
Gürsoy M; Büyükuysal RL
Neurochem Res; 2008 Sep; 33(9):1838-44. PubMed ID: 18438711
[TBL] [Abstract][Full Text] [Related]
2. Anoxia-induced dopamine release from rat striatal slices: involvement of reverse transport mechanism.
Büyükuysal RL; Mete B
J Neurochem; 1999 Apr; 72(4):1507-15. PubMed ID: 10098855
[TBL] [Abstract][Full Text] [Related]
3. Effect of nitric oxide donors on endogenous dopamine release from rat striatal slices. II: The role of voltage-dependent sodium channels, calcium channel activation, reverse transport mechanism, guanylate cyclase and endogenous glutamate.
Büyükuysal RL
Fundam Clin Pharmacol; 1997; 11(6):528-36. PubMed ID: 9444520
[TBL] [Abstract][Full Text] [Related]
4. Dopaminergic toxicity of the herbicide atrazine in rat striatal slices.
Filipov NM; Stewart MA; Carr RL; Sistrunk SC
Toxicology; 2007 Mar; 232(1-2):68-78. PubMed ID: 17218051
[TBL] [Abstract][Full Text] [Related]
5. Transmitter release by non-receptor activation of the alpha-subunit of guanine nucleotide regulatory protein in rat striatal slices.
Zelles T; Chernaeva L; Baranyi M; Déri Z; Adam-Vizi V; Vizi ES
J Neurosci Res; 1995 Oct; 42(2):242-51. PubMed ID: 8568925
[TBL] [Abstract][Full Text] [Related]
6. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study.
Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
J Neurochem; 1988 Feb; 50(2):346-55. PubMed ID: 2447237
[TBL] [Abstract][Full Text] [Related]
7. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
Sirinathsinghji DJ; Heavens RP; McBride CS
Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
[TBL] [Abstract][Full Text] [Related]
8. A possible role of nitric oxide in the regulation of dopamine transporter function in the striatum.
Kiss JP; Hennings EC; Zsilla G; Vizi ES
Neurochem Int; 1999 Apr; 34(4):345-50. PubMed ID: 10372921
[TBL] [Abstract][Full Text] [Related]
9. Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals.
Snyder GL; Keller RW; Zigmond MJ
J Pharmacol Exp Ther; 1990 May; 253(2):867-76. PubMed ID: 2110978
[TBL] [Abstract][Full Text] [Related]
10. In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: I. Studies using veratrine and ouabain.
Fairbrother IS; Arbuthnott GW; Kelly JS; Butcher SP
J Neurochem; 1990 Jun; 54(6):1834-43. PubMed ID: 2338544
[TBL] [Abstract][Full Text] [Related]
11. The effect of nicotine in combination with various dopaminergic drugs on nigrostriatal dopamine in rats.
Janhunen S; Mielikäinen P; Paldánius P; Tuominen RK; Ahtee L; Kaakkola S
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jun; 371(6):480-91. PubMed ID: 16012872
[TBL] [Abstract][Full Text] [Related]
12. Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain.
Karoum F; Chrapusta SJ; Brinjak R; Hitri A; Wyatt RJ
Br J Pharmacol; 1994 Dec; 113(4):1391-9. PubMed ID: 7889297
[TBL] [Abstract][Full Text] [Related]
13. Methyl-4-phenylpyridinium (MPP(+))-evoked dopamine release from rat striatal slices: possible roles of voltage-dependent calcium channels and reverse dopamine transport.
Inazu M; Kubota N; Takeda H; Oguchi K; Koizumi M; Kimura S; Matsumiya T
Neurochem Int; 2001 Sep; 39(3):253-60. PubMed ID: 11434982
[TBL] [Abstract][Full Text] [Related]
14. Effect of nitric oxide donors on endogenous dopamine release from rat striatal slices. I: Requirement to antioxidants in the medium.
Büyükuysal RL
Fundam Clin Pharmacol; 1997; 11(6):519-27. PubMed ID: 9444519
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous recording of the release of nigral and striatal dopamine in the awake rat.
Santiago M; Westerink BH
Neurochem Int; 1992 Mar; 20 Suppl():107S-110S. PubMed ID: 1365406
[TBL] [Abstract][Full Text] [Related]
16. 5-HT3 receptor agonist induced carrier-mediated release of dopamine in rat striatum in vivo.
Santiago M; Machado A; Cano J
Br J Pharmacol; 1995 Sep; 116(1):1545-50. PubMed ID: 8564217
[TBL] [Abstract][Full Text] [Related]
17. Complex I inhibitor effect on the nigral and striatal release of dopamine in the presence and absence of nomifensine.
Santiago M; Granero L; Machado A; Cano J
Eur J Pharmacol; 1995 Jul; 280(3):251-6. PubMed ID: 8566093
[TBL] [Abstract][Full Text] [Related]
18. Release of endogenous dopamine, 3,4-dihydroxyphenylacetic acid, and amino acid transmitters from rat striatal slices.
Flint RS; Murphy JM; McBride WJ
Neurochem Res; 1985 Apr; 10(4):515-27. PubMed ID: 2860579
[TBL] [Abstract][Full Text] [Related]
19. Delta 9-tetrahydrocannabinol facilitates striatal dopaminergic transmission.
Sakurai-Yamashita Y; Kataoka Y; Fujiwara M; Mine K; Ueki S
Pharmacol Biochem Behav; 1989 Jun; 33(2):397-400. PubMed ID: 2554342
[TBL] [Abstract][Full Text] [Related]
20. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
Hara S; Mukai T; Kurosaki K; Kuriiwa F; Endo T
Arch Toxicol; 2002 Oct; 76(10):596-605. PubMed ID: 12373456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
